Drug profile · INN
epalrestat
epalrestat is a aldose reductase inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — epalrestat
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.70
Quick answer
epalrestat is a aldose reductase inhibitor.
Key facts
INN epalrestat
Mechanism Aldose reductase inhibitor
Target Aldo-keto reductase family 1 member B1
Mechanism of action
Aldose reductase inhibitor
Primary target: Aldo-keto reductase family 1 member B1
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Frequently asked questions
What is epalrestat?
epalrestat is a aldose reductase inhibitor.